Detalles de la búsqueda
1.
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
N Engl J Med
; 374(26): 2542-52, 2016 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27093365
2.
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Clin Ther
; 25(6): 1700-21, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12860493
3.
Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
J Rheumatol
; 41(4): 648-57, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24584918
4.
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial.
Arch Dermatol
; 144(2): 200-7, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18283176
5.
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
J Rheumatol
; 30(12): 2563-71, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14719195
6.
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
Arthritis Rheum
; 50(5): 1400-11, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15146409
7.
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
Arthritis Rheum
; 48(1): 35-45, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12528101
Resultados
1 -
7
de 7
1
Próxima >
>>